Literature DB >> 8900333

Risk stratification in coronary artery disease and special populations.

R O Bonow1, N Bohannon, W Hazzard.   

Abstract

In patients with coronary artery disease (CAD), left ventricular (LV) function, the number of diseased vessels, and the severity of myocardial ischemia are important determinants of survival. These factors can be used to identify subsets of high-risk patients who are candidates for aggressive intervention. Among patients with LV dysfunction, those with left main CAD, three-vessel disease, and one- or two-vessel disease with inducible ischemia are at highest risk. High-risk subsets among those with preserved LV function include patients with left main CAD and those with inducible ischemia and either three-vessel disease or two-vessel disease with involvement of the proximal left anterior descending coronary artery. Thus, exercise testing, assessment of ventricular function and, in selected patients, coronary angiography to determine coronary anatomy are valuable tools in risk stratification. In the primary-care setting, patient characteristics such as gender, race, age, and concomitant medical conditions may also be most useful in identifying high-risk patients. Although women in general have some primary protection against premature CAD, especially prior to the menopause, coronary risk in women who have experienced a cardiovascular event is similar to that in men. Coronary mortality is increased in minority populations, and the presence of other risk factors, such as diabetes and hyperlipidemia, can further increase this risk. Up to 80% of diabetic patients die of cardiovascular disease, 75% of which is CAD. The risk in this population is exacerbated by the abnormalities in lipid metabolism associated with the diabetic state. CAD mortality increases with aging, but it is recommended that elderly patients with CAD also receive risk factor intervention, such as cholesterol-lowering therapy. Consideration of the impact of such therapy on quality of life is especially important in initiating such interventions in the older population.

Entities:  

Mesh:

Year:  1996        PMID: 8900333     DOI: 10.1016/s0002-9343(96)00312-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

1.  The role of radionuclide myocardial perfusion imaging for asymptomatic individuals.

Authors:  Robert C Hendel; Brian G Abbott; Timothy M Bateman; Ron Blankstein; Dennis A Calnon; Jeffrey A Leppo; Jamshid Maddahi; Matthew M Schumaecker; Leslee J Shaw; R Parker Ward; David G Wolinsky
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

2.  Relationship between glycemic control and coronary artery disease severity, prevalence and plaque characteristics by computed tomography coronary angiography in asymptomatic type 2 diabetic patients.

Authors:  C A F Tavares; C H R E Rassi; M G Fahel; B L Wajchenberg; C E Rochitte; A C Lerario
Journal:  Int J Cardiovasc Imaging       Date:  2016-07-18       Impact factor: 2.357

3.  Coronary artery plaque volume and obesity in patients with diabetes: the factor-64 study.

Authors:  Alan C Kwan; Heidi T May; George Cater; Christopher T Sibley; Boaz D Rosen; João A C Lima; Karen Rodriguez; Donald L Lappe; Joseph B Muhlestein; Jeffrey L Anderson; David A Bluemke
Journal:  Radiology       Date:  2014-04-22       Impact factor: 11.105

4.  Serial changes on quantitative myocardial perfusion SPECT in patients undergoing revascularization or conservative therapy.

Authors:  D S Berman; X Kang; E F Schisterman; J Gerlach; P B Kavanagh; J S Areeda; T Sharir; S W Hayes; L J Shaw; H C Lewin; J D Friedman; R Miranda; G Germano
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

5.  Microalbuminuria predicts silent myocardial ischaemia in type 2 diabetes patients.

Authors:  Giampiero Giovacchini; Mario Cappagli; Stefano Carro; Sandro Borrini; Antonella Montepagani; Rossella Leoncini; Gianfranco Mazzotta; Gianmario Sambuceti; Giuliano Mariani; Duccio Volterrani; Michael J Zellweger; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-12       Impact factor: 9.236

6.  Evaluating gender differences in prognosis following SPECT myocardial perfusion imaging among patients with diabetes and known or suspected coronary disease in the modern era.

Authors:  Maria Theresa H Santos; Matthew W Parker; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-08-21       Impact factor: 5.952

7.  Characteristic changes in coronary artery at the early hyperglycaemic stage in a rat type 2 diabetes model and the effects of pravastatin.

Authors:  J Kajikuri; Y Watanabe; Y Ito; R Ito; T Yamamoto; T Itoh
Journal:  Br J Pharmacol       Date:  2009-07-23       Impact factor: 8.739

8.  Metabolomic and flux-balance analysis of age-related decline of hypoxia tolerance in Drosophila muscle tissue.

Authors:  Laurence Coquin; Jacob D Feala; Andrew D McCulloch; Giovanni Paternostro
Journal:  Mol Syst Biol       Date:  2008-12-16       Impact factor: 11.429

9.  Early detection of asymptomatic coronary artery disease in patients with type 2 diabetes mellitus.

Authors:  Won Sang Yoo; Hee Jin Kim; Dohee Kim; Myung Yong Lee; Hyun-Kyung Chung
Journal:  Korean J Intern Med       Date:  2009-08-26       Impact factor: 3.165

10.  Screening asymptomatic patients with diabetes for unknown coronary artery disease: does it reduce risk? An open-label randomized trial comparing a strategy based on exercise testing aimed at revascularization with management based on pharmacological/behavioural treatment of traditional risk factors. DADDY-D Trial (Does coronary Atherosclerosis Deserve to be Diagnosed and treated early in Diabetics?).

Authors:  Fabrizio Turrini; Roberto Messora; Paolo Giovanardi; Stefano Tondi; Paolo Magnavacchi; Rita Cavani; Giandomenico Tosoni; Carlo Cappelli; Elisa Pellegrini; Stefania Romano; Augusto Baldini; Romeo Giulietto Zennaro; Marco Bondi
Journal:  Trials       Date:  2009-12-23       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.